Another Stem Cell Company Is Put On Notice

The FDA has notified another company —the 46th this year—that the unapproved stem cell products it sells for a number of illnesses likely are subject to regulation under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act.
Source: JAMA - Category: General Medicine Source Type: research